LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:
This replaces the announcement made at 12:13 PM Europe (Paris, Rome, Berlin, Frankfurt) on Tuesday 5 September 2017 due to the following corrections: the section "5. Origin of the change" has been modified to: Capital increase resulting from (i) a contribution in kind by minority shareholders of France Biologie Management and (ii) the exercise of stock options and redeemable warrants (BSAAR).
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 August 2017
Eurofins Scientific SE (Paris:ERF):
Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities
1. Identity of the issuer or the underlying issuer of existing shares to
which voting rights are attachedi (including the issuer ID
allocated by the CSSF)
EUROFINS SCIENTIFIC SE – E1013
2. Identity of the notifier (if another person makes the notification on behalf of the issuer) N/ A
3. Total number of shares composing the share capital of the notifying
4. Total number of voting rights attached to the shares composing the
share capital of the notifying issuer, including the suspended voting
5. Origin of the changeiii
Capital increase resulting from (i) a contribution in kind by minority shareholders of France Biologie Management and (ii) the exercise of stock options and redeemable warrants (BSAAR).
6. Date when the change occurred
31 August 2017
i Either the full name of the legal entity or another method
for identifying the issuer or underlying issuer, provided it is reliable
ii For further details on the total number of voting rights, please refer to point 1(b) of circular CSSF 08/349.
iii As, for example, a capital increase or reduction.